These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31348908)

  • 1. Pre-analytical stability of novel cerebrospinal fluid biomarkers.
    Willemse EAJ; Vermeiren Y; Garcia-Ayllon MS; Bridel C; De Deyn PP; Engelborghs S; van der Flier WM; Jansen EEW; Lopez-Font IB; Mendes V; Manadas B; de Roeck N; Saez-Valero J; Struys EA; Vanmechelen E; Andreasson U; Teunissen CE
    Clin Chim Acta; 2019 Oct; 497():204-211. PubMed ID: 31348908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid.
    Willemse EA; Durieux-Lu S; van der Flier WM; Pijnenburg YA; de Jonge R; Teunissen CE
    J Alzheimers Dis; 2016 Apr; 53(1):107-16. PubMed ID: 27104901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.
    Simonsen AH; Bahl JM; Danborg PB; Lindstrom V; Larsen SO; Grubb A; Heegaard NH; Waldemar G
    J Neurosci Methods; 2013 May; 215(2):234-40. PubMed ID: 23537933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers.
    Hok-A-Hin YS; Willemse EAJ; Teunissen CE; Del Campo M
    Methods Mol Biol; 2019; 2044():27-50. PubMed ID: 31432404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
    Ogawa S; Tsuchimine S; Kunugi H
    J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Pre-Analytical Stability of Small-Molecule Metabolites in Cerebrospinal Fluid Using Direct-Infusion Metabolomics.
    Haijes HA; Willemse EAJ; Gerrits J; van der Flier WM; Teunissen CE; Verhoeven-Duif NM; Jans JJM
    Metabolites; 2019 Oct; 9(10):. PubMed ID: 31635433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.
    Koel-Simmelink MJ; Vennegoor A; Killestein J; Blankenstein MA; Norgren N; Korth C; Teunissen CE
    J Immunol Methods; 2014 Jan; 402(1-2):43-9. PubMed ID: 24275679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40).
    Vanderstichele H; Demeyer L; Janelidze S; Coart E; Stoops E; Mauroo K; Herbst V; François C; Hansson O
    Alzheimers Res Ther; 2017 Jun; 9(1):40. PubMed ID: 28587660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.
    Schoonenboom NS; Mulder C; Vanderstichele H; Van Elk EJ; Kok A; Van Kamp GJ; Scheltens P; Blankenstein MA
    Clin Chem; 2005 Jan; 51(1):189-95. PubMed ID: 15539465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid.
    Kruse N; Mollenhauer B
    J Immunol Methods; 2015 Nov; 426():70-5. PubMed ID: 26271436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting.
    Gervaise-Henry C; Watfa G; Albuisson E; Kolodziej A; Dousset B; Olivier JL; Jonveaux TR; Malaplate-Armand C
    J Alzheimers Dis; 2017; 57(2):437-445. PubMed ID: 28269771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-use stability of monoamine metabolites in human cerebrospinal fluid.
    Strawn JR; Ekhator NN; Geracioti TD
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):301-6. PubMed ID: 11530989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission.
    Garrett MC; Soares-da-Silva P
    J Neurochem; 1992 Jan; 58(1):101-6. PubMed ID: 1309230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA; Bowden CL; Maas JW
    J Chromatogr; 1984 Dec; 336(2):259-69. PubMed ID: 6085084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M; Chang WH; Kirk KL; Linnoila M
    Anal Biochem; 1983 May; 131(1):246-53. PubMed ID: 6193730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations.
    Verbeek MM; Blom AM; Wevers RA; Lagerwerf AJ; van de Geer J; Willemsen MA
    Mol Genet Metab; 2008 Nov; 95(3):127-32. PubMed ID: 18722797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cystatin C Cleavage ELISA Assay as a Quality Control Tool for Determining Sub-Optimal Storage Conditions of Cerebrospinal Fluid Samples in Alzheimer's Disease Research.
    Mommaerts K; Willemse EAJ; Marchese M; Larue C; van der Flier WM; Betsou F; Teunissen CE
    J Alzheimers Dis; 2021; 83(3):1367-1377. PubMed ID: 34420976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.